secwatch.observer — SEC 8-K summary
======================================

Issuer:     BXP, Inc. (BXP)
CIK:        0001037540
Form:       8-K
Filed at:   2022-10-26T23:59:59+00:00
Accession:  0001656423-22-000039
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BXP Q3 EPS $2.29 beats mid-point by $1.54; FFO $1.91; 2023 guidance lower
-------------------------------------------------------------------------

- Revenue $790.5M (+8.3% YoY); net income $361M ($2.29 EPS); FFO $299.8M ($1.91).
- EPS beat included $1.50 gain on sale of 601 Mass Ave ($531M gross); FFO beat by $0.04.
- FY2022 EPS guidance $5.55-$5.57, FFO $7.51-$7.53; FY2023 EPS $2.27-$2.42, FFO $7.15-$7.30.
- Leased 1.4M SF in Q3; acquired 125 Broadway lab in Kendall Sq for ~$592.4M; disposed 601 Mass Ave and land parcels.
- Agreed to acquire ~27% interest in 200 Fifth Ave, NYC for ~$280.2M and sell Avant residential for ~$141M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1037540/000165642322000039/0001656423-22-000039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1037540/000165642322000039/bxp-20221025.htm
  HTML page:      https://secwatch.observer/filing/0001656423-22-000039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer